Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Cohen Global, Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06739707
- Locations
- 🇮🇱
Sheba Medical Center, Ramat-gan, Please select, Israel
Subcutaneous Administration of MD-18 in Healthy Subjects
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Cohen Global, Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT06259903
- Locations
- 🇮🇱
Sheba Medical Center, Ramat-gan, Please select, Israel
News
No news found